Breaking News on Contract Research, Manufacturing & Clinical Trials

Japan’s PuRec to supply mesenchymal stem cells

05-Feb-2016 - Regenerative medicine developers now have a new supplier for mesenchymal stem cells (MSCs), the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue...

Update - facility expansion to continue

Therapure postpones IPO citing market conditions

04-Feb-2016 - Therapure Biopharma has postponed its IPO citing market conditions.

Piramal to invest $10m to add ADC capacity at Coldstream lab

04-Feb-2016 - Piramal has announced its intention to invest $10m (€8.9m) in Coldstream Laboratories, the US sterile injectable CDMO it bought last year.

VC Renaissance: Index Ventures spin off Medicxi launches GSK and J&J backed €210m fund

03-Feb-2016 - Biologics developers backed by Medicxi Ventures’ new €210m ($229m) fund will use Lonza for contract manufacturing under an existing deal with Index Ventures .

Novasep expands API lab to grow US sales after Pharmachem divestiture

02-Feb-2016 - Novasep has announced it is expanding API synthesis its facility in Boothwyn, Pennsylvania and confirmed that US growth is important after the sale of Pharmachem.


Quintiles: challenges and moving forward as an industry

01-Feb-2016 - To move forward as an industry, CROs must focus on the patient and build strategic partnerships, says Quintiles executive.

Amatsigroup buys Q Biologicals in 'fragmented' EU bio-services space

27-Jan-2016 - French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.

Recipharm raises $32m to fund Nitin deal

27-Jan-2016 - Recipharm has raised SEK276m ($32m) to part finance the acquisition of a majority stake in Indian CMO Nitin Life Sciences that it announced in October.

Austrianova rolls out cell banking and fill finish services

27-Jan-2016 - Austrianova has launched cell banking and fill finish services for cell therapy developers at its facility in Singapore.

Hermes adapts food coating technique for API taste masking

26-Jan-2016 - Hermes Pharma has added hot melt coating capabilities to its offering and hopes the food industry technique will win it pharma customers with unpleasant tasting APIs.

Catalent continues to scout acquisitions and licensing in 2016

25-Jan-2016 - Catalent will pursue strategic acquisitions and licensing in 2016, said VP Marketing & Strategy Elliott Berger, noting growth areas include complex delivery technologies and specialised logistics.

Catalent bringing clinical supply services to Japanese facility

21-Jan-2016 - Catalent will expand its cGMP facility in Japan to bring secondary packaging and clinical supply services to the region.

Johnson Matthey expands Cambridge catalysis facility

21-Jan-2016 - Johnson Matthey has expanded its UK biocatalysis R&D operations in response to growing drug industry demand.

Novozymes says pharma won't drive growth and sets up albumin subsidiary

20-Jan-2016 - Novozymes has launched its albumin operations as a stand-alone subsidiary and reiterated that its pharma business is no longer a growth driver.

Rx-to-OTC switching: the heart of OTC market, says GBI Research

19-Jan-2016 - Drug manufacturers, regulators, and consumers are increasing pressure on pharma companies to make the Rx-to-OTC switch, as non-prescription medications are cheaper and easier to access.

When are CMOs used? ISR reports

19-Jan-2016 - While CMOs are currently engaged mainly through tactical outsourcing, this paradigm will shift as more companies begin outsourcing to preferred providers, says ISR  report.

Colorcon sweetens its offering with Paulaur's pharma sugar sphere biz

19-Jan-2016 - Colorcon has acquired Paulaur Corporation’s sugar sphere business to help feed pharma’s demand for multiparticulate dosage forms.

Deal-making will offset drug development costs in 2016, says analyst

14-Jan-2016 - As it becomes increasingly expensive to develop drugs, analysts predict that deal-making will become more important for pharmaceutical companies seeking to offset R&D costs.

Exclusive interview

India has 'natural potential to grow' in CRO space, says Syngene CEO

14-Jan-2016 - India’s CRO industry is playing catch-up to the generic and manufacturing sectors, according to the departing CEO of one of the largest players, Syngene.

Vaccine contract manufacturing market to undergo shift, says analyst

12-Jan-2016 - According to analysts, the vaccine contract manufacturing market is poised for growth, and change, as new players emerge in the East.

Focused R&D is key to productivity according to Deloitte

12-Jan-2016 - As annual projected pharmaceutical R&D returns continue to decline and companies are under increasing pressure, focus may be the defining factor.

AMRI's Burlington to produce cancer drug in JV with Eagle

11-Jan-2016 - A chemotherapy drug marketed by Eagle Pharmaceuticals has become the first product approved for commercial manufacture from AMRI’s once troubled Burlington facility.

Strategic partnership aligns MG America and COMAS

04-Jan-2016 - MG America, the US subsidiary of MG2 Bologna, Italy, is expanding its filling division through a recent strategic partnership with COMAS.

Recipharm signs agreement with Alcon, expands services

22-Dec-2015 - Recipharm AB announced yesterday that it has entered into a strategic collaboration with Alcon, a Novartis company.

Sweden to back biomanufacturing through SEK320m investment scheme

18-Dec-2015 - The Swedish Government has announced a multi-million kronor plan to back biopharmaceutical research and manufacturing in the country.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...